Levemex 500 Tablet contains Levetiracetam 500mg, an antiepileptic medication primarily indicated for the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby stabilizing neuronal activity and reducing seizure propagation. It is commonly prescribed as adjunctive therapy in adults and pediatric patients aged four years and above. Levemex 500 is well-absorbed orally with rapid onset of action and exhibits linear pharmacokinetics, allowing for flexible dosing adjustments based on clinical response and tolerability. The medication is generally well-tolerated; however, potential adverse effects include dizziness, somnolence, irritability, and fatigue. Serious but rare side effects may involve behavioral changes, mood disturbances, and hypersensitivity reactions. Caution is advised in patients with renal impairment, necessitating dose modification to prevent accumulation. Levemex 500 should be used under strict medical supervision with regular monitoring to evaluate therapeutic efficacy and adverse effects. It is contraindicated in patients with known hypersensitivity to Levetiracetam or any of its excipients. Patient adherence and periodic neurological assessment are essential to optimize seizure control and improve quality of life.